Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy.

Abstract

BACKGROUND We have shown that rIL-2 administration in recurrent head and neck cancers induces a tumor-specific T-lymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5-fluorouracil. Long-term results are not known. METHODS Thirty patients with recurrent-persistent head and… (More)

Topics

Cite this paper

@article{Airoldi2001SurvivalIP, title={Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy.}, author={Michela Airoldi and Alberta de Stefani and Sara Marchionatti and Fulvia Pedani and Peter Gabriele and Riccardo Ragona and Giorgio Cortesina and Cesare Bumma}, journal={Head & neck}, year={2001}, volume={23 4}, pages={298-304} }